Table 2 Prognostic value of 7-gene signature in different pathological stages of KIRC in the TCGA cohort
From: A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma
| Â | Number of samples | Number of Death (%) | Hazard Ratio | 95% CI | P Value |
|---|---|---|---|---|---|
Stage I | 214 | 35 (16) | 5.16 | 2.07–12.87 | 0.0004 |
Stage II | 42 | 7 (17) | 1.15 | 0.11–11.54 | 0.908 |
Stage III | 116 | 46 (40) | 2.12 | 1.05–4.27 | 0.037 |
Stage IV | 71 | 56 (79) | 3.73 | 1.67–8.32 | 0.001 |